Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
FDA
6 months ago
Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch
This is a major relief for the pharmaceutical industry company as it paves the way for an earlier-than-expected approval and launch of cancer drug gAbraxane.
1 year ago
Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
1 year ago
Why This Pharma Firm's Shares Are Sinking After US FDA Notice
6 months ago
Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch
1 year ago
Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
1 year ago
Why This Pharma Firm's Shares Are Sinking After US FDA Notice
Loading...